Searchable abstracts of presentations at key conferences in endocrinology

ea0035p117 | Calcium and Vitamin D metabolism | ECE2014

New vitamin D less-calcemic analog affects human bone cell line and cultured vascular smooth muscle cells similar to other analogs

Somjen Dalia , Kulesza Urszula , Sharon Orli , Knoll Esther , Stern Naftali

Vitamin D receptors (VDRs) are expressed in bone and vascular cells which also respond to vitamin D treatment by modulation of cell proliferation measured by DNA synthesis and energy metabolism measured by CK specific activity. We have previously observed that vitamin D-related compounds target several genes which affect cell proliferation, including mRNA expression of estrogen receptor (ER)α, ERβ, VDR, 1α hydroxylase of 25OHD3 (1OHase) and 12 and 15 lipoxygenas...

ea0041ep1090 | Thyroid cancer | ECE2016

Differential expression of mRNA of the vitamin D receptor, 1α-hydroxylase 25-hydroxy vitamin D and estrogen receptors in human explants and cell cultures of thyroid cancer and normal tissues

Somjen Dalia , Sharon Orli , Knoll Esther , Aizic Abraham , Fliss David , Limor Rona , Stern Naftali , Izkhakov Elena

Several studies indicated that estrogen receptors (ERs) and vitamin D receptor (VDR), as well 1α-hydroxylase 25-hydroxy vitamin D (1OHase) are expressed in various normal and cancerous cell types. To date, there are no reported studies on the different expressions of VDR, 1OHase and ERs, in human thyroid normal and cancer cells. This study addresses these questions. Tissues harvested from papillary thyroid cancer (PTC) and normal glands explants were used throughout eithe...

ea0037oc8.4 | Endocrine tumours | ECE2015

The effects of peptides with oestrogen-like activity on cell proliferation and on energy metabolism in human derived tumour cell lines

Somjen Dalia , Katzburg Sara , Gayer Batya , Kasher Roni , Kohen Forune , Sharon Orli , Stern Naftali

Oestradiol-17β regulates diverse tissues and cells, both within and outside the reproductive system including human cancer cells. Currently used ERs agonists or antagonists are synthetic compounds prepared by structure modifications. Alternatively, peptide mimics of steroids would allow preparation of biased combinatorial libraries of chemical and biological origin, from which estrogenic peptides with tissue selective profiles can be selected. The phage-display peptide li...